Latest Issue

Industrialising Drug Delivery163

Issue No #163 July 2024 July 16th, 2024

Inside the magazine

FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN

INDUSTRIALISATION

Lorenzo Vaccarella

Paragon Medical

FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN

Lorenzo Vaccarella highlights six critical areas to consider early in the drug delivery device development journey. He discusses how strategically investing time during the early stages of the design cycle and throughout development can ultimately save both time and cost down the road when the product is being manufactured and deployed into the market.

DELIVERING INTELLIGENT AUTOINJECTOR ASSEMBLY SOLUTIONS FOR COMPLEX CUSTOMER-SPECIFIC REQUIREMENTS

INDUSTRIALISATION

Lars Keinicke Hansen

Stevanato Group

DELIVERING INTELLIGENT AUTOINJECTOR ASSEMBLY SOLUTIONS FOR COMPLEX CUSTOMER-SPECIFIC REQUIREMENTS

Lars Keinicke Hansen discusses the potential of technology to enhance the efficiency and productivity of manufacturing processes for both pharmaceutical companies and contract development and manufacturing organisations, as well as the skills and expertise required to maximise the potential gains technology can offer.

FROM IDEA TO MASS PRODUCTION: RAPIDLY AND SAFELY INDUSTRIALISING INNOVATIONS

INDUSTRIALISATION

Michael Wiglenda

FROM IDEA TO MASS PRODUCTION: RAPIDLY AND SAFELY INDUSTRIALISING INNOVATIONS

Michael Wiglenda describes Gerresheimer’s approach to the industrialisation of drug delivery devices, using the production of the company’s Gx Inbeneo^® cartridge-based autoinjector as an example.

AUTOMATING HIGH-MIX, LOW-TO-MEDIUM-VOLUME AUTOINJECTOR ASSEMBLY

INDUSTRIALISATION

AUTOMATING HIGH-MIX, LOW-TO-MEDIUM-VOLUME AUTOINJECTOR ASSEMBLY

Colby Chen and Ian Chang discuss how the introduction of modularity can close the gap in traditional assembly systems to enable fully automated, high-quality autoinjector assembly in support of low- volume/high-mix manufacturing.

YPSOMED’S PLATFORM PRODUCT TRANSFORMATION AND APPROACH TO STRATEGIC PARTNER NETWORKING FOR SELF-INJECTION DEVICES

INDUSTRIALISATION

YPSOMED’S PLATFORM PRODUCT TRANSFORMATION AND APPROACH TO STRATEGIC PARTNER NETWORKING FOR SELF-INJECTION DEVICES

Ian Thompson describes how Ypsomed has transformed the market for platform-based self-injection devices and extended the concept of platform products beyond the core device by developing working practices with strategic networking partners, helping pharma companies and patients to source safe, reliable and easy-to-use drug-device combination products.

MACHINABILITY OF ETFE-FILM-COATED PREFILLED SYRINGE PLUNGER WITH VENT-TUBE INSERTION

INDUSTRIALISATION

Sebastien Cordier

MACHINABILITY OF ETFE-FILM-COATED PREFILLED SYRINGE PLUNGER WITH VENT-TUBE INSERTION

Sebastien Cordier, Benjamin Brocco, Audrey Chardonnet and Edgar Bauer discuss the results of tests on the performance of PremiumCoat^® syringe plungers on high-speed fill-finish operations with vented insertion.

MATERIAL SELECTION & EFFICIENT DEVELOPMENT PROCESSES FOR WEARABLE INJECTOR DRIVE SYSTEMS

Dave Beckstoffer

MATERIAL SELECTION & EFFICIENT DEVELOPMENT PROCESSES FOR WEARABLE INJECTOR DRIVE SYSTEMS

Dave Beckstoffer explains the importance of material selection in drive system development, the key attributes of materials towards a wearable and auto-delivery device, and discusses the need to achieve industrialisation based on material selection and relevant manufacturing processes.

IMPLEMENTING INDUSTRY 4.0: LESSONS LEARNED OVER TWO DECADES

INDUSTRIALISATION

IMPLEMENTING INDUSTRY 4.0: LESSONS LEARNED OVER TWO DECADES

Herman Rusch and Rob van den Brand present four lessons for implementing Industry 4.0 technology and practices in the drug delivery industry, which IGS GeboJagema has learned during its own journey to Industry 4.0 over the past 20 years.

USING EFFICIENT PROOF-OF-CONCEPT TESTS AND PILOT MOULDS FOR DEVICE DEVELOPMENT SUCCESS

USING EFFICIENT PROOF-OF-CONCEPT TESTS AND PILOT MOULDS FOR DEVICE DEVELOPMENT SUCCESS

Andreas Wild and Andreas Montag discuss the value of early proof-of-concept testing and sample production for drug delivery device development projects, with an emphasis on how partnership and consultation can smooth and enhance this process, including for design for automation and design for manufacturing considerations.

Top